Climb Bio Reports Third-Quarter 2026 Financial Results
Climb Bio said Phase 1 data in healthy volunteers showed sustained >90% free APRIL suppression and ~70% Gd-.
Climb Bio said Phase 1 data in healthy volunteers showed sustained >90% free APRIL suppression and ~70% Gd-.